Page 4 - Recursion Pharmaceuticals News Today

Recursion is playing the long game with its AI-focused approach to drug discovery and development.

Cherry Creek Investment Advisors Inc. bought a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund bought 17,853 shares of the company’s stock, valued at approximately $176,000. Other large investors have also recently made changes to their positions in […]

The GPU maker hopes to make a bigger splash in a market that accounts for 18% of the U.S. GDP.

The GPU maker hopes to make a bigger splash in a market that accounts for 18% of the U.S. GDP.

The GPU maker hopes to make a bigger splash in a market that accounts for 18% of the U.S. GDP.

Nvidia is sharing its newfound wealth by investing in other artificial intelligence (AI) stocks.

This stock's upside is huge, but so is its downside.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott sold 8,000 shares of the company’s stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $10.75, for a total value of $86,000.00. Following the completion of the sale, the chief operating officer now directly owns 639,982 […]

The reigning king of AI has made several AI-related investments, but one is the biggest and arguably the best.

Mellanox Technologies, 3dfx Interactive, MediaQ, and Hybrid Graphics were all acquired by the leading supplier of graphics processors.